Jeremy L. Davis

Dr. Jeremy L. Davis is a Professor of Surgery at the University of Maryland School of Medicine, with a secondary appointment in Biochemistry & Molecular Biology. He serves as Chief of the Division of Surgical Oncology and is the Principal Investigator of the Precancer Genomics Lab. Dr. Davis is a board-certified surgical oncologist specializing in complex and rare cancers of the digestive tract and abdominal organs, performing operations on the stomach, liver, pancreas, and intestines using both traditional and minimally invasive techniques.

Dr. Davis's research focuses on understanding cancer at its earliest stages, particularly studying the genomic landscape of precancerous cells and their microenvironment. His work seeks to identify vulnerabilities and unlock strategies for cancer interception. He is internationally recognized as a leader in the management of people with hereditary gastric and lobular breast cancers, with significant research on CDH1 gene mutations. His research spans multiple areas including gastric cancer, liver cancer, breast cancer, and molecular mechanisms of cancer development.

Dr. Davis's publication record shows a consistent focus on surgical oncology, cancer genomics, and hereditary cancer syndromes. His recent work (2023-2025) demonstrates an increasing emphasis on single-cell analysis, multi-omic profiling, and spatial analysis of tumor microenvironments. His research bridges clinical practice with basic science, particularly in understanding how genetic mutations like CDH1 lead to cancer development and how these processes can be intercepted.

Dr. Davis completed his MD at University of South Florida Morsani College of Medicine (2005), followed by residencies at Indiana University School of Medicine (2007, 2013), and fellowships at Memorial Sloan-Kettering Cancer Center and NCI Surgical Oncology Research and Immunotherapy program. He is board certified in Surgery (2013) and Complex General Surgical Oncology (2016).